No Data
Meikang Biotech: Report for the first quarter of 2025
Medicalsystem Biotechnology (300439.SZ) released its first-quarter performance, with a net income of 30.3977 million yuan, a decrease of 61.57%.
Medicalsystem Biotechnology (300439.SZ) released its first quarter report for 2025, with a revenue of 3.74...
Meikang Biotech: 2024 Annual Report
Meikang Biotech: 2024 Annual Report Summary
MedicalSystem Biotechnology's Subsidiary Receives Registration Certificate for Fully Automatic Biochemical Analyzer
Medicalsystem Biotechnology (300439.SZ) subsidiary has obtained a medical instruments registration certificate.
Medicalsystem Biotechnology (300439.SZ) announces that its wholly-owned subsidiary Ningbo Medicalsystem Shengde Biotechnology Co., Ltd. (abbreviated...
Investors Don't See Light At End Of Medicalsystem Biotechnology Co., Ltd's (SZSE:300439) Tunnel